CDEK by Data4ThePeople

Sign in Sign up

← All organizations

The Immune Response Corporation

For profit

Also known as: Immune Response BioPharma | Immune Response BioPharma, Inc. | Immune Response BioPharma, Inc. Chief R&D Officer

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2017

Defunct as of Nov 2, 2009

Timeline

1980s

Jun 1, 1986
The Immune Response Corporation— Founded

2000s

Nov 2, 2009
The Immune Response Corporation— Defunct

Drugs by trial phase (4 distinct, 9 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT02200718Study directorPhase 1Nov 1, 2017
NCT02200718Lead sponsorPhase 1Nov 1, 2017
NCT02291809Lead sponsorPhase 2Nov 1, 2017
NCT02291809Study directorPhase 2Nov 1, 2017
NCT02366026Lead sponsorPhase 3Jun 1, 2017
NCT02366026Study directorPhase 3Jun 1, 2017
NCT02149706Study directorPhase 2Mar 1, 2017
NCT02149706Lead sponsorPhase 2Mar 1, 2017
NCT02057159Lead sponsorPhase 2/Phase 3Feb 1, 2017
NCT02057159Study directorPhase 2/Phase 3Feb 1, 2017
NCT00006153CollaboratorPhase 1Aug 7, 2000
NCT00002173Lead sponsorN/ANov 2, 1999
NCT00002359Lead sponsorPhase 3Nov 2, 1999
NCT00002172Lead sponsorN/ANov 2, 1999

Details

Founded: Carlsbad, CA, US Jun 1, 1986
Last known activity: Nov 1, 2017